研究文章
活性炭的临床效果不可用口服药物中毒患者的治疗结果
表4
GCS和临床结果相比charcoal-available和charcoal-unavailable时期之间。
|
|
Charcoal-available时期 |
Charcoal-unavailable时期 |
p -价值__ |
| Non-charcoal |
木炭 |
总 |
p -价值 |
|
| 吸入性肺炎 |
|
|
|
|
|
|
| GCS 13 - 15 |
7 (4.0%) |
7 (7.4%) |
14 (5.2%) |
0.258 |
3 (2.1%) |
0.119 |
| GCS 9 - 12 |
7 (13.7%) |
3 (10.7%) |
10 (12.7%) |
> 0.990 |
4 (10.8%) |
> 0.999 |
| GCS 3 - 8 |
14 (29.2%) |
3 (15.8%) |
17 (25.4%) |
0.356 |
14 (36.8%) |
0.216 |
| 插管 |
|
|
|
|
|
|
| GCS 13 - 15 |
3 (1.7%) |
6 (6.4%) |
9 (3.4%) |
0.071 |
3 (2.1%) |
0.552 |
| GCS 9 - 12 |
5 (9.8%) |
4 (14.3%) |
9 (11.4%) |
0.713 |
3 (8.1%) |
0.749 |
| GCS 3 - 8 |
9 (18.8%) |
8 (47.1%) |
17 (25.4%) |
0.064 |
10 (26.3%) |
0.915 |
| 血管加压的使用 |
|
|
|
|
|
|
| GCS 13 - 15 |
7 (4.0%) |
3 (3.2%) |
10 (3.7%) |
> 0.990 |
5 (3.4%) |
0.868 |
| GCS 9 - 12 |
4 (7.8%) |
1 (3.6%) |
5 (6.3%) |
0.651 |
1 (2.7%) |
0.663 |
| GCS 3 - 8 |
6 (12.5%) |
1 (5.3%) |
7 (10.4%) |
0.663 |
5 (13.2%) |
0.753 |
| 死亡率 |
|
|
|
|
|
|
| GCS 13 - 15 |
3 (1.7%) |
1 (1.1%) |
4 (1.5%) |
> 0.990 |
1 (0.7%) |
0.660 |
| GCS 9 - 12 |
1 (2.0%) |
0 (0%) |
1 (1.3%) |
> 0.990 |
1 (2.7%) |
0.538 |
| GCS 3 - 8 |
3 (6.3%) |
0 (0%) |
3 (4.5%) |
0.553 |
0 (0%) |
0.552 |
| 住院 |
|
|
|
|
|
|
| GCS 13 - 15 |
50 (28.9%) |
39 (41.5%) |
89例(33.3%) |
0.037 |
28 (19.2%) |
0.002 |
| GCS 9 - 12 |
26 (51.0%) |
17 (60.7%) |
43 (54.4%) |
0.046 |
15 (40.5%) |
0.163 |
| GCS 3 - 8 |
36 (75.6%) |
11 (57.9%) |
47 (70.1%) |
0.168 |
23 (60.5%) |
0.315 |
| ICU住院 |
|
|
|
|
|
|
| GCS 13 - 15 |
2 (1.2%) |
6 (6.4%) |
8 (3.0%) |
0.024 |
12 (8.2%) |
0.028 |
| GCS 9 - 12 |
3 (5.9%) |
2 (7.1%) |
5 (6.3%) |
> 0.990 |
6 (16.2%) |
0.102 |
| GCS 3 - 8 |
7 (14.6%) |
4 (21.1%) |
11 (16.4%) |
0.492 |
12 (31.6%) |
0.071 |
| 的患者数量 |
|
|
|
|
|
|
| GCS 13 - 15 |
173年 |
94年 |
267年 |
|
146年 |
|
| GCS 9 - 12 |
51 |
28 |
79年 |
|
37 |
|
| GCS 3 - 8 |
48 |
19 |
67年 |
|
38 |
|
|
|
gc:格拉斯哥昏迷评分;ICU:重症监护室。
noncharcoal和木炭。
__charcoal-available和charcoal-unavailable时期之间。
|
